跳至主要内容
临床试验/NCT05098678
NCT05098678已完成不适用

The Effects of Zinc Gluconate Supplementation on Several Genes Expression, the Serum Level of Inflammatory Factors, Quality of Life, and Disease Activity in Patients With Behcet Syndrome: Double-blind Randomized Controlled Clinical Trial

Tabriz University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Serum level of zinc

研究概览

简要总结

To study the effects of zinc gluconate supplementation on patients with Behçet's syndrome, 50 patients will be randomly allocated to two groups: placebo group or zinc group (one tablet of 30 mg/day elemental zinc) for 12 weeks. All participants will be asked not to alter their diet, medication, and physical activity during the study. At the first and the end of the intervention, genes and proteins expression, the serum level of inflammatory factors, quality of life, disease activity, anthropometric measures, physical activity and serum level of zinc will be assessed and compared between groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age range 20 to 50 years (premenopausal woman)
  • Diagnosis of Behcet's disease by a rheumatologist according to IBCD (The International Criteria for Behcet's Disease)
  • Patients who want to participate in the study

排除标准

  • Pregnancy and lactation
  • History of diabetes and other chronic diseases
  • Smoking and alcohol consumption over the past year
  • History of other autoimmune diseases
  • Consumption of nutritional and antioxidant supplements over two months prior to the study

结局指标

主要结局

Serum level of zinc

时间窗: 12 weeks

ug/dl

Toll-like Receptor-4 gene expression

时间窗: 12 weeks

2-ΔΔCT

Toll-like Receptor-2 protein expression

时间窗: 12 weeks

The mean fluorescence intensity

Toll-like Receptor-4 protein expression

时间窗: 12 weeks

The mean fluorescence intensity

Caspase-1 gene expression

时间窗: 12 weeks

2-ΔΔCT

Serum level of interleukin-1 beta

时间窗: 12 weeks

pg/ml

Toll-like Receptor-2 gene expression

时间窗: 12 weeks

2-ΔΔCT

Serum level of tumor necrosis factor-alpha

时间窗: 12 weeks

pg/ml

NLRP3 gene expression

时间窗: 12 weeks

2-ΔΔCT

次要结局

  • Behçet's disease quality-of-life(12 weeks)
  • Disease activity(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Beitullah Alipour

Beitullah Alipour, Ph.D., Prof.

Tabriz University of Medical Sciences

研究点 (1)

Loading locations...

相似试验